Cerecor Inc. (CERC) to Release Quarterly Earnings on Monday
Cerecor (NASDAQ:CERC) last released its quarterly earnings results on Monday, August 14th. The company reported ($0.14) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.29) by $0.15. Cerecor had a negative return on equity of 1,325.84% and a negative net margin of 1,106.99%. The business had revenue of $0.16 million during the quarter. On average, analysts expect Cerecor to post $-0.8 EPS for the current fiscal year and $-0.86 EPS for the next fiscal year.
Shares of Cerecor Inc. (CERC) opened at 0.98 on Monday. The firm’s 50-day moving average price is $0.92 and its 200 day moving average price is $0.71. The company’s market cap is $25.53 million. Cerecor Inc. has a 12-month low of $0.34 and a 12-month high of $5.60.
In related news, major shareholder Armistice Capital Master Fund purchased 219,792 shares of the business’s stock in a transaction on Monday, August 21st. The shares were bought at an average cost of $0.60 per share, with a total value of $131,875.20. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders have acquired a total of 1,638,693 shares of company stock worth $1,053,475 over the last ninety days. 10.70% of the stock is owned by insiders.
Cerecor Company Profile
Cerecor, Inc is a clinical stage biopharmaceutical company. The Company is engaged in developing drug candidates for patients with neurological and psychiatric disorders. The Company has a portfolio of clinical and preclinical compounds that it is developing for a range of indications, including CERC-301, which is an adjunctive treatment for major depressive disorder (MDD); CERC-501, which is for substance use disorders and adjunctive treatment of MDD, and CERC-406, which is for the treatment of cognitive impairment.
Receive News & Ratings for Cerecor Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerecor Inc. and related companies with MarketBeat.com's FREE daily email newsletter.